MLICM
ICVX

Metropolitan Life Insurance Company (MetLife)’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,497
Closed -$23.6K – 2366
2023
Q4 		$23.6K Hold
1,497
– – ﹤0.01% 1843
2023
Q3 		$11.6K Hold
1,497
– – ﹤0.01% 2150
2023
Q2 		$14.9K Hold
1,497
– – ﹤0.01% 2088
2023
Q1 		$8.68K Hold
1,497
– – ﹤0.01% 2206
2022
Q4 		$11.9K Buy
+1,497
New +$6.42K ﹤0.01% 2229
2022
Q2 		– Sell
-1,796
Closed -$12.6K – 2455
2022
Q1 		$12.6K Sell
1,796
-2,181
-55% -$34.3K ﹤0.01% 2227
2021
Q4 		$91K Hold
3,977
– – ﹤0.01% 2535
2021
Q3 		$118K Buy
+3,977
New +$135K ﹤0.01% 2433

Metropolitan Life Insurance Company (MetLife)'s ICVX Position: Q1 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 1,497 shares — an estimated $23.6K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ICVX in Q3 2021 and held it in 8 quarters. The position peaked at $118K in Q3 2021. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,497 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $23.6K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Icosavax, Inc. Common Stock position peaked at $118K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2024, filed 14 May 2024.